Compare SRTA & PWRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SRTA | PWRL |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 530.4M | 475.2M |
| IPO Year | 2019 | 2025 |
| Metric | SRTA | PWRL |
|---|---|---|
| Price | $4.48 | $12.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $9.56 | N/A |
| AVG Volume (30 Days) | ★ 758.6K | 180.0K |
| Earning Date | 11-09-2026 | N/A |
| Dividend Yield | N/A | ★ 2.02% |
| EPS Growth | ★ 242.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $197,141,000.00 | N/A |
| Revenue This Year | $47.51 | N/A |
| Revenue Next Year | $12.14 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.95 | $9.41 |
| 52 Week High | $6.50 | $16.31 |
| Indicator | SRTA | PWRL |
|---|---|---|
| Relative Strength Index (RSI) | 29.64 | 58.75 |
| Support Level | $4.21 | $10.36 |
| Resistance Level | $4.69 | $12.57 |
| Average True Range (ATR) | 0.18 | 0.55 |
| MACD | -0.05 | 0.09 |
| Stochastic Oscillator | 11.39 | 67.31 |
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.
Powerlaw Corp is a non-diversified, closed-end management investment company. The Fund's investment objective is long-term capital appreciation. It seeks to achieve its investment objective by investing in the equity and equity-linked securities of a concentrated portfolio of approximately 12 to 15 late-stage technology companies.